Drug Shortage Report for MINT-LOSARTAN/HCTZ DS
Report ID | 80811 |
Drug Identification Number | 02389673 |
Brand name | MINT-LOSARTAN/HCTZ DS |
Common or Proper name | losartan/HCTZ |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 25.0MG 100.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 count bottles |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-04-08 |
Estimated end date | |
Actual end date | 2020-07-10 |
Shortage status | Resolved |
Updated date | 2020-07-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2020-07-13 | French | Compare |
v12 | 2020-07-13 | English | Compare |
v11 | 2020-04-25 | French | Compare |
v10 | 2020-04-25 | English | Compare |
v9 | 2020-01-27 | French | Compare |
v8 | 2020-01-27 | English | Compare |
v7 | 2019-10-21 | French | Compare |
v6 | 2019-10-21 | English | Compare |
v5 | 2019-07-04 | French | Compare |
v4 | 2019-07-04 | English | Compare |
v3 | 2019-04-09 | English | Compare |
v2 | 2019-04-08 | French | Compare |
v1 | 2019-04-08 | English | Compare |
Showing 1 to 13 of 13